The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADICET BIO INC | COM | 007002108 | 3,332 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
| AMYRIS INC | COM NEW | 03236M200 | 4,839 | 352,445 | SH | SOLE | 352,445 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 17,258 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| BERKELEY LTS INC | COM | 084310101 | 3,951 | 201,996 | SH | SOLE | 201,996 | 0 | 0 | ||
| BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 3,254 | 257,267 | SH | SOLE | 257,267 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 13,646 | 1,622,591 | SH | SOLE | 1,622,591 | 0 | 0 | ||
| CYTEIR THERAPEUTICS INC | COM | 23284P103 | 5,608 | 319,538 | SH | SOLE | 319,538 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 16,003 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 14,770 | 1,175,000 | SH | SOLE | 1,175,000 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 14,681 | 575,940 | SH | SOLE | 575,940 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 10,036 | 406,986 | SH | SOLE | 406,986 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 4,060 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| LEAP THERAPEUTICS INC | COM | 52187K101 | 4,812 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| MEDAVAIL HOLDINGS INC | COM | 58406B103 | 8,529 | 2,920,780 | SH | SOLE | 2,920,780 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 7,643 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 16,806 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 9,210 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 8,882 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 8,720 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| NATERA INC | COM | 632307104 | 29,866 | 268,000 | SH | SOLE | 268,000 | 0 | 0 | ||
| NUVATION BIO INC | COM CL A | 67080N101 | 16,510 | 1,660,947 | SH | SOLE | 1,660,947 | 0 | 0 | ||
| INVITAE CORP | COM | 46185L103 | 5,683 | 199,900 | SH | SOLE | 199,900 | 0 | 0 | ||
| REPLIGEN CORP | COM | 759916109 | 20,229 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 8,089 | 437,960 | SH | SOLE | 437,960 | 0 | 0 | ||
| SIGHT SCIENCES INC | COM | 82657M105 | 7,770 | 342,304 | SH | SOLE | 342,304 | 0 | 0 | ||
| SOMALOGIC INC | CLASS A COM | 83444K105 | 9,912 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 15,376 | 3,439,895 | SH | SOLE | 3,439,895 | 0 | 0 | ||
| VERVE THERAPEUTICS INC | COM | 92539P101 | 705 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 14,887 | 904,978 | SH | SOLE | 904,978 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | CALL | 03753U906 | 9,888 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
| SPDR SER TR | PUT | 78464A950 | 25,142 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |